Fig. 1From: The influence of baseline characteristics, treatment and depression on health-related quality of life in patients with multiple myeloma: a prospective observational studySignificant influence of participation in clinical trials on HRQoL. a Before start of treatment. b 3Â months after the end of treatmentBack to article page